Andreas W Schreiber Selected Research

Therapeutics

11/2021	Targeted gene panels identify a high frequency of pathogenic germline variants in patients diagnosed with a hematological malignancy and at least one other independent cancer.
12/2019	The mutational burden of therapy-related myeloid neoplasms is similar to primary myelodysplastic syndrome but has a distinctive distribution.
1/2019	Identification and targeted management of a neurodegenerative disorder caused by biallelic mutations in SLC5A6.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andreas W Schreiber Research Topics

Disease

8	Neoplasms (Cancer) 01/2022 - 09/2013
3	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2023 - 08/2017
3	Blast Crisis (Blast Phase) 01/2020 - 08/2017
2	Hematologic Neoplasms (Hematological Malignancy) 01/2022 - 12/2019
1	Hypersensitivity (Allergy) 02/2023
1	Perinatal Death 01/2023
1	Renal Cell Carcinoma (Grawitz Tumor) 12/2020
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 12/2020
1	Paraganglioma (Paragangliomas) 12/2020
1	Pituitary Neoplasms (Pituitary Adenoma) 12/2020
1	Carcinogenesis 01/2020
1	Pituitary ACTH Hypersecretion 01/2020
1	Pseudodiastrophic dysplasia 01/2020
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 12/2019
1	Prolactinoma (Prolactinomas) 12/2019
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2019
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2019
1	Autoimmune Diseases (Autoimmune Disease) 07/2017
1	Partial Epilepsies (Epilepsy, Partial) 01/2016
1	Sensorineural Hearing Loss 08/2015
1	Allan-Herndon-Dudley syndrome 08/2015
1	Sarcoma (Soft Tissue Sarcoma) 02/2014

Drug/Important Bio-Agent (IBA)

4	RNA (Ribonucleic Acid)IBA 01/2022 - 02/2014
4	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 09/2013
2	Imatinib Mesylate (Gleevec)FDA Link 01/2023 - 08/2017
2	NucleotidesIBA 01/2023 - 09/2013
2	Messenger RNA (mRNA)IBA 01/2018 - 02/2014
1	Thrombopoietin (c-mpl Ligand)IBA 02/2023
1	Succinate Dehydrogenase (Fumarate Reductase)IBA 12/2020
1	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 01/2020
1	Retinoid X Receptor gammaIBA 01/2020
1	Core Binding Factor Alpha 2 SubunitIBA 01/2020
1	Proteoglycans (Proteoglycan)IBA 01/2020
1	VitaminsIBA 01/2019
1	Biotin (Vitamin H)FDA Link 01/2019
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2018
1	MicroRNAs (MicroRNA)IBA 01/2018
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 07/2017
1	TOR Serine-Threonine KinasesIBA 01/2016
1	Thyroid HormonesIBA 08/2015
1	Nonsense Codon (Nonsense Mutation)IBA 08/2015
1	Microphthalmia-Associated Transcription FactorIBA 08/2015
1	nutlin 3IBA 02/2014
1	Biomarkers (Surrogate Marker)IBA 02/2014
1	Cytostatic AgentsIBA 02/2014

Therapy/Procedure

3	Therapeutics 11/2021 - 01/2019
1	Drug Therapy (Chemotherapy) 12/2019
1	Radiotherapy 12/2019